ArticlePharmacological reports : PR2026

The onset of posterior reversible encephalopathy syndrome (PRES) and reversible cerebral vasoconstriction syndrome (RCVS) with the use of decongestant agents: a European pharmacovigilance analysis.

Antonietta Anatriello et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.